Trial Profile
Multicenter, randomized, double-blind, parallel group, placebo-controlled study of the analgesic efficacy of XP20B [dextropropoxyphene-napsilate/paracetamol] in subjects with pain following bunionectomy surgery
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2008
Price :
$35
*
At a glance
- Drugs Dextropropoxyphene/paracetamol (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Xanodyne Pharmaceuticals
- 07 Oct 2008 Actual end date (August 2008) added as reported by CT.gov
- 07 Oct 2008 Status changed from recruiting to completed as reported by CT.gov
- 01 May 2008 New trial record.